(Q35259843)

7 August 2017

title

Urinary N-acetyl-beta-D-glucosaminidase activity in patients with cystic fibrosis on long-term gentamicin inhalation (English)

1 reference

7 August 2017

0 references

0 references

Ring E

1

1 reference

7 August 2017

Eber E

series ordinal

2

1 reference

7 August 2017

Erwa W

series ordinal

3

1 reference

7 August 2017

Zach MS

series ordinal

4

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

Archives of Disease in Childhood

7 August 2017

published in

1 reference

7 August 2017

volume

78

1 reference

7 August 2017

issue

6

1 reference

7 August 2017

page(s)

540-543

1 reference

A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717603

Nebulised antipseudomonal antibiotic therapy in cystic fibrosis: a meta-analysis of benefits and risks

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717603

Functional parameters and 99mtechnetium-dimercaptosuccinic acid scan in acute pyelonephritis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717603

Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717603

Inhaled antibiotics in cystic fibrosis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717603

Urinary enzymes, nephrotoxicity and renal disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717603

Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717603

Quantitative deposition of aerosolized gentamicin in cystic fibrosis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717603

Renal tubular proteinuria and microalbuminuria in diabetic patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717603

Renal function in cystic fibrosis: proteinuria and enzymuria before and after tobramycin therapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717603

Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717603

Lung disease in cystic fibrosis--an updated concept

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717603

Enzymuria as a marker of renal injury and disease: studies of N-acetyl-beta-glucosaminidase in the general population and in patients with renal disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717603

Inhalation of antibiotics in cystic fibrosis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717603

Efficacy of aerosolized tobramycin in patients with cystic fibrosis.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717603

Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis

26 September 2018

1 reference

12 December 2020

The effects of age and urine concentration on lysozyme and N-acetyl-beta-D-glucosaminidase (NAG) content in urine

1 reference

12 December 2020

Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection

1 reference

12 December 2020

Inhaled ceftazidime compared with gentamicin and carbenicillin in older patients with cystic fibrosis infected with Pseudomonas aeruginosa

1 reference

12 December 2020

Interpretation of excessive levels of inhaled tobramycin

1 reference

12 December 2020

Long-term tobramycin aerosol therapy in cystic fibrosis

1 reference

12 December 2020

[N-acetyl-beta-D-glucosaminidase (NAG) in the urine. An additional parameter for diagnosing the site of urinary tract infection]

1 reference

12 December 2020

Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosis

1 reference

12 December 2020

Assessment of potential ototoxicity following high-dose nebulized tobramycin in patients with cystic fibrosis

1 reference

12 December 2020

The quantitative distribution of nebulized antibiotic in the lung in cystic fibrosis

1 reference

12 December 2020

Identifiers

DOI

10.1136/ADC.78.6.540

1 reference

7 August 2017

1 reference

7 August 2017

1 reference